Back to Search
HARRY SUTHERLAND, MD
MD
Neurology Physician
NPI: 1881259554IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
75464(CT)
Education
OTHER
Class of 2019
Research & Publications (20)
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
PMID 19597425·Bone Marrow Transplant·2010
8-other
Ten things your emergency department should consider to prepare for pandemic influenza.
PMID 19546270·Emerg Med J·2009
8-other
KRAB zinc-finger proteins localise to novel KAP1-containing foci that are adjacent to PML nuclear bodies.
PMID 19258395·J Cell Sci·2009
7-preclinical
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
PMID 19167680·Biol Blood Marrow Transplant·2009
8-other
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels.
PMID 18762338·Leuk Res·2009
8-other
Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet.
PMID 18697839·FASEB J·2008
7-preclinical
Pegylated liposomal doxorubicin plus bortezomib in relapsed or refractory multiple myeloma: efficacy and safety in patients with renal function impairment.
PMID 19064400·Clin Lymphoma Myeloma·2008
8-other
G9a histone methyltransferase contributes to imprinting in the mouse placenta.
PMID 18039842·Mol Cell Biol·2008
7-preclinical
Therapeutic stimulation of denervated muscles: the influence of pattern.
PMID 18563723·Muscle Nerve·2008
7-preclinical
Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
PMID 18679372·Bone Marrow Transplant·2008
8-other
Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results.
PMID 18695664·Bone Marrow Transplant·2008
8-other
Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
PMID 17453971·Cytotherapy·2007
7-preclinical
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression.
PMID 17679727·J Clin Oncol·2007
3-trial
Effects of chronic electrical stimulation on long-term denervated muscles of the rabbit hind limb.
PMID 17906933·J Muscle Res Cell Motil·2007
7-preclinical
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes.
PMID 17158775·Ann Oncol·2007
8-other
Atrophy, but not necrosis, in rabbit skeletal muscle denervated for periods up to one year.
PMID 17218372·Am J Physiol Cell Physiol·2007
7-preclinical
Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia.
PMID 17442662·Ann Oncol·2007
8-other
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
PMID 17640596·Biol Blood Marrow Transplant·2007
3-trial
Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting.
PMID 18092005·PLoS One·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 800 Howard Ave Lowr Level
New Haven, CT 06519 - Phone
- (877) 925-3329
Quick Facts
- NPI
- 1881259554
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile